DoD Rare Cancers, Resource and Community Development Award
ID: 358795Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Defense (DOD) is initiating the FY25 Rare Cancers Research Program Resource and Community Development Award, funding approximately $5.6 million for projects aimed at enhancing research resources and supporting clinical data related to rare cancers. Eligibility is extended to both domestic and foreign non-profit or for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. Key focus areas include integrating patient advocates throughout the project, creating robust community building strategies, and ensuring the sustainability of research platforms developed via grant funding. The program seeks to address significant gaps in rare cancer research—such as inadequate resources, lack of communication strategies, and insufficient data-sharing infrastructure. The funding supports both clinical and preclinical research, encouraging the development of extensive datasets and repositories. Ethical considerations, including the sequential involvement of patient advocates, are central to the award mechanism. A detailed two-step application process is outlined, culminating in a thorough review for scientific merit and program relevance, leading to recommendations for funding decisions by the DOD. Overall, the initiative aims to significantly improve therapeutic outcomes and knowledge-sharing within the rare cancer research community.
    Similar Opportunities
    Loading similar opportunities...